Multiple endocrine neoplasia type 1 laboratory findings
Multiple endocrine neoplasia type 1 Microchapters |
Differentiating Multiple endocrine neoplasia type 1 from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Multiple endocrine neoplasia type 1 laboratory findings On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 1 laboratory findings |
FDA on Multiple endocrine neoplasia type 1 laboratory findings |
CDC on Multiple endocrine neoplasia type 1 laboratory findings |
Multiple endocrine neoplasia type 1 laboratory findings in the news |
Blogs on Multiple endocrine neoplasia type 1 laboratory findings |
Directions to Hospitals Treating Multiple endocrine neoplasia type 1 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 1 laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [3]
Overview
Laboratory findings consistent with the diagnosis of multiple endocrine neoplasia type 1 include increased parathyroid hormone, increased gastrin concentration, and increased cortisol concentration.
Laboratory Findings
Laboratory tests may be performed periodically to screen for multiple endocrine neoplasia type 1 tumors[1][2]
Blood Tests
Urine Tests
References
- ↑ [1] MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1 NCI
- ↑ Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML (2012). "Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)". J. Clin. Endocrinol. Metab. 97 (9): 2990–3011. doi:10.1210/jc.2012-1230. PMID 22723327.